Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
23andMe’s Q3 Topline Beat Estimates On Boost From Telehealth Business Acquisition
23andMe Holding Co (NASDAQ: ME) has updated its FY22 guidance following the inclusion of telehealth operations into its consumer business.
23andMe Holding Q4 EPS $(0.21) Misses $(0.16) Estimate, Sales $57.00M Beat $54.30M Estimate
23andMe Holding (NASDAQ:ME) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 31.25 percent. The company reported quarterly sales of $57.00 million which beat the
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell
• Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.